Alzheimer's disease: A lesson from mitochondrial dysfunction

被引:122
|
作者
Moreira, Paula I.
Santos, Maria S.
Oliveira, Catarina R. [1 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Inst Physiol, Fac Med, Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Inst Physiol, Coimbra, Portugal
[4] Univ Coimbra, Fac Sci & Technol, Dept Zool, Coimbra, Portugal
[5] Univ Coimbra, Fac Med, Inst Biochem, Coimbra, Portugal
关键词
D O I
10.1089/ars.2007.1703
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease. Mitochondria are a major source of intracellular reactive oxygen species and are particularly vulnerable to oxidative stress. This review discusses evidence supporting the notion that mitochondrial dysfunction is intimately associated with Alzheimer's disease pathogenesis. Furthermore, the potential connection between mitochondrial dysfunction/oxidative stress and autophagy in Alzheimer's disease is also discussed. As a result of insufficient digestion of oxidatively damaged macromolecules and organelles by autophagy, neurons progressively accumulate lipofuscin (biological garbage) that could exacerbate neuronal dysfunction. The knowledge that mitochondrial dysfunction has a preponderant role in several pathological conditions instigated the development of mitochondrial antioxidant therapies. Mitochondria-targeted antioxidant treatments are briefly discussed in this review.
引用
收藏
页码:1621 / 1630
页数:10
相关论文
共 50 条
  • [1] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [2] Mitochondrial dysfunction in Alzheimer's disease
    D'Alessandro, Maria Clara Bila
    Kanaan, Salim
    Geller, Mauro
    Pratico, Domenico
    Daher, Joao Paulo Lima
    AGEING RESEARCH REVIEWS, 2025, 107
  • [3] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [4] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [5] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [6] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    GENES & GENOMICS, 2017, 39 (03) : 295 - 300
  • [7] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03): : 407 - 410
  • [8] Mitochondrial dysfunction in models of Alzheimer's disease
    Eckert, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 23 - 23
  • [9] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [10] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300